Jonathan Wolleben Score: 20
Analyst at
JMP Securities
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+12.7%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
60%
9 W / 6 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
18%
2 W / 9 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 11 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 11 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
57%
8 W / 6 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
60%
9 W / 6 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Nov 05, 2025 |
Biocryst Pharmaceuticals Inc.
BCRX
|
BUY |
$25.00
Est. +259%
|
$6.97 | $11.22 |
Pending
|
$9.51
+36.4%
|
| Oct 01, 2025 |
Ocular Therapeutix Inc
OCUL
|
BUY |
$29.00
Est. +148%
|
$11.69 | $16.42 |
Pending
|
$8.59
-26.6%
|
| Sep 26, 2025 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$143.00
Est. +211%
|
$45.91 | $84.02 |
Pending
|
$83.72
+82.4%
|
| Sep 25, 2025 |
Rhythm Pharmaceuticals Inc.
RYTM
|
BUY |
$142.00
Est. +44%
|
$98.76 | $122.20 |
Pending
|
$103.97
+5.3%
|
| Aug 07, 2025 |
Mirum Pharmaceuticals Inc
MIRM
|
BUY |
$81.00
Est. +35%
|
$59.82 | $130.00 |
Target Met
|
$114.48
+91.4%
|
| Mar 26, 2025 |
Aura Biosciences Inc
AURA
|
BUY |
$19.00
Est. +217%
|
$5.99 | $7.48 |
Miss
|
$7.01
+17.0%
|
| Sep 17, 2024 |
Rhythm Pharmaceuticals Inc.
RYTM
|
BUY |
$64.00
Est. +19%
|
$54.00 | $106.52 |
Target Met
|
$103.97
+92.5%
|
| Sep 10, 2024 |
Skye Bioscience Inc
SKYE
|
BUY |
$15.00
Est. +136%
|
$6.35 | $7.08 |
Miss
|
$0.64
-89.9%
|
| Aug 13, 2024 |
Savara Inc
SVRA
|
BUY |
$9.00
Est. +120%
|
$4.10 | $4.70 |
Miss
|
$5.65
+37.8%
|
| Aug 09, 2024 |
Structure Therapeutics Inc - ADR
GPCR
|
BUY |
$86.00
Est. +149%
|
$34.49 | $45.37 |
Miss
|
$50.41
+46.2%
|
| Jun 27, 2024 |
Savara Inc
SVRA
|
BUY |
$10.00
Est. +405%
|
$1.98 | $5.11 |
Miss
|
$5.65
+185.4%
|
| Apr 11, 2024 |
Pharvaris NV
PHVS
|
BUY |
$50.00
Est. +125%
|
$22.27 | $25.50 |
Miss
|
$34.36
+54.3%
|
| Mar 20, 2024 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$80.00
Est. +76%
|
$45.49 | $62.53 |
Miss
|
$83.72
+84.0%
|
| Mar 15, 2024 |
Madrigal Pharmaceuticals Inc
MDGL
|
BUY |
$397.00
Est. +47%
|
$270.37 | $377.46 |
Miss
|
$537.65
+98.9%
|
| Mar 12, 2024 |
Ocular Therapeutix Inc
OCUL
|
BUY |
$24.00
Est. +158%
|
$9.29 | $11.77 |
Miss
|
$8.59
-7.6%
|
Biocryst Pharmaceuticals Inc.
BCRX
Nov 05, 2025
Signal & Target
BUY
$25.00
Start Price
$6.97
Best Price (1Y)
$11.22
Current Price
$9.51
Return
+36.4%
Ocular Therapeutix Inc
OCUL
Oct 01, 2025
Signal & Target
BUY
$29.00
Start Price
$11.69
Best Price (1Y)
$16.42
Current Price
$8.59
Return
-26.6%
Crinetics Pharmaceuticals Inc
CRNX
Sep 26, 2025
Signal & Target
BUY
$143.00
Start Price
$45.91
Best Price (1Y)
$84.02
Current Price
$83.72
Return
+82.4%
Rhythm Pharmaceuticals Inc.
RYTM
Sep 25, 2025
Signal & Target
BUY
$142.00
Start Price
$98.76
Best Price (1Y)
$122.20
Current Price
$103.97
Return
+5.3%
Mirum Pharmaceuticals Inc
MIRM
Aug 07, 2025
Signal & Target
BUY
$81.00
Start Price
$59.82
Best Price (1Y)
$130.00
Current Price
$114.48
Return
+91.4%
Aura Biosciences Inc
AURA
Mar 26, 2025
Signal & Target
BUY
$19.00
Start Price
$5.99
Best Price (1Y)
$7.48
Current Price
$7.01
Return
+17.0%
Rhythm Pharmaceuticals Inc.
RYTM
Sep 17, 2024
Signal & Target
BUY
$64.00
Start Price
$54.00
Best Price (1Y)
$106.52
Current Price
$103.97
Return
+92.5%
Skye Bioscience Inc
SKYE
Sep 10, 2024
Signal & Target
BUY
$15.00
Start Price
$6.35
Best Price (1Y)
$7.08
Current Price
$0.64
Return
-89.9%
Savara Inc
SVRA
Aug 13, 2024
Signal & Target
BUY
$9.00
Start Price
$4.10
Best Price (1Y)
$4.70
Current Price
$5.65
Return
+37.8%
Structure Therapeutics Inc - ADR
GPCR
Aug 09, 2024
Signal & Target
BUY
$86.00
Start Price
$34.49
Best Price (1Y)
$45.37
Current Price
$50.41
Return
+46.2%
Savara Inc
SVRA
Jun 27, 2024
Signal & Target
BUY
$10.00
Start Price
$1.98
Best Price (1Y)
$5.11
Current Price
$5.65
Return
+185.4%
Pharvaris NV
PHVS
Apr 11, 2024
Signal & Target
BUY
$50.00
Start Price
$22.27
Best Price (1Y)
$25.50
Current Price
$34.36
Return
+54.3%
Crinetics Pharmaceuticals Inc
CRNX
Mar 20, 2024
Signal & Target
BUY
$80.00
Start Price
$45.49
Best Price (1Y)
$62.53
Current Price
$83.72
Return
+84.0%
Madrigal Pharmaceuticals Inc
MDGL
Mar 15, 2024
Signal & Target
BUY
$397.00
Start Price
$270.37
Best Price (1Y)
$377.46
Current Price
$537.65
Return
+98.9%
Ocular Therapeutix Inc
OCUL
Mar 12, 2024
Signal & Target
BUY
$24.00
Start Price
$9.29
Best Price (1Y)
$11.77
Current Price
$8.59
Return
-7.6%